Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT
Moots RJ, Fortune F, Jackson R, Thornburn T, Morgan AW, Carr D, Murray PI, Wallace GR, Situnayake D
Record ID 32015000704
English
Original Title:
Optimal utilisation of biologic drugs in Behcet's Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/eme/1220546/#/
Year Published:
2024
URL for published report:
https://www.journalslibrary.nihr.ac.uk/eme/HTFC6304
Requestor:
NIHR Health Technology Assessment programme
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Interferon-alpha
- Infliximab
- Immunosuppressive Agents
- Behcet Syndrome
- Metabolomics
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.